MIME-Version: 1.0
Content-Location: file:///C:/A7B3EC56/e2c929065bd9466d95086f998928f8a6.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="utf-8"

<html xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:dt=3D"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8">
<meta name=3DProgId content=3DOneNote.File>
<meta name=3DGenerator content=3D"Microsoft OneNote 15">
<link id=3DMain-File rel=3DMain-File href=3De2c929065bd9466d95086f998928f8a=
6.htm>
<link rel=3DFile-List href=3D"e2c929065bd9466d95086f998928f8a6.files/fileli=
st.xml">
</head>

<body lang=3Dzh-TW style=3D'font-family:Calibri;font-size:11.0pt'>

<div style=3D'direction:ltr;border-width:100%'>

<div style=3D'direction:ltr;margin-top:0in;margin-left:0in;width:6.9201in'>

<div style=3D'direction:ltr;margin-top:0in;margin-left:.3312in;width:6.5055=
in'>

<p style=3D'margin:0in;font-size:20.0pt;color:black' lang=3Den-US><span
style=3D'font-weight:bold;font-family:"Microsoft JhengHei"'>靜脈血栓栓=
塞症（</span><span
style=3D'font-weight:bold;font-family:"Calibri Light"'>Venous Thromboemboli=
sm,
VTE</span><span style=3D'font-weight:bold;font-family:"Microsoft JhengHei"'=
>）</span></p>

</div>

<div style=3D'direction:ltr;margin-top:.0388in;margin-left:.3312in;width:2.=
4333in'>

<p style=3D'margin:0in;font-family:Calibri;font-size:10.0pt;color:#767676'
lang=3Den-US>Tuesday, March 25, 2025</p>

<p style=3D'margin:0in;font-family:Calibri;font-size:10.0pt;color:#767676'
lang=3Den-US>11:21 PM</p>

</div>

<div style=3D'direction:ltr;margin-top:.3965in;margin-left:0in;width:6.9201=
in'>

<ul style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:=
0in'>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>編輯格=
式</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>顏色=
記方式</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
zh-TW>重要標題</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
en-US> :
        </span><span style=3D'font-family:"Microsoft JhengHei";font-size:11=
.0pt;
        color:#1E4E79' lang=3Dzh-TW>母標題藍色</span><span style=3D'fo=
nt-family:"Microsoft JhengHei";
        font-size:11.0pt;color:#1E4E79' lang=3Den-US>(</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:#1=
E4E79'
        lang=3Dzh-TW>最暗</span><span style=3D'font-family:"Microsoft Jhe=
ngHei";
        font-size:11.0pt;color:#1E4E79' lang=3Den-US>)</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:#1=
E4E79'
        lang=3Dzh-TW>標記</span><span style=3D'font-family:"Microsoft Jhe=
ngHei";
        font-size:11.0pt' lang=3Den-US>/</span><span style=3D'font-family:"=
Microsoft JhengHei";
        font-size:11.0pt;color:#2E75B5' lang=3Dzh-TW>子標題藍色</span>=
<span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:#2=
E75B5'
        lang=3Den-US>(</span><span style=3D'font-family:"Microsoft JhengHei=
";
        font-size:11.0pt;color:#2E75B5' lang=3Dzh-TW>較暗</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:#2=
E75B5'
        lang=3Den-US>,25%)</span><span style=3D'font-family:"Microsoft Jhen=
gHei";
        font-size:11.0pt;color:#2E75B5' lang=3Dzh-TW>標記</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
zh-TW>重要術式治療藥物</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
en-US> :
        </span><span style=3D'font-weight:bold;font-family:"Microsoft Jheng=
Hei";
        font-size:11.0pt;color:#70AD47' lang=3Dzh-TW>綠色標記</span><sp=
an
        style=3D'font-weight:bold;font-family:"Microsoft JhengHei";font-siz=
e:
        11.0pt;color:#70AD47' lang=3Den-US>+</span><span style=3D'font-weig=
ht:bold;
        font-family:"Microsoft JhengHei";font-size:11.0pt;color:#70AD47'
        lang=3Dzh-TW>粗體</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
zh-TW>重要內文</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
en-US> :
        </span><span style=3D'font-family:"Microsoft JhengHei";font-size:11=
.0pt;
        color:#C00000' lang=3Dzh-TW>紅色</span><span style=3D'font-family=
:"Microsoft JhengHei";
        font-size:11.0pt;color:#C00000' lang=3Den-US>(</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C=
00000'
        lang=3Dzh-TW>標準色彩</span><span style=3D'font-family:"Microso=
ft JhengHei";
        font-size:11.0pt;color:#C00000' lang=3Den-US>)</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
en-US>/</span><span
        style=3D'font-weight:bold;font-family:"Microsoft JhengHei";font-siz=
e:
        11.0pt;color:#ED7D31' lang=3Dzh-TW>橘色</span><span style=3D'font=
-weight:
        bold;font-family:"Microsoft JhengHei";font-size:11.0pt;color:#ED7D3=
1'
        lang=3Den-US>+</span><span style=3D'font-weight:bold;font-family:"M=
icrosoft JhengHei";
        font-size:11.0pt;color:#ED7D31' lang=3Dzh-TW>粗體</span><span
        style=3D'font-weight:bold;font-family:"Microsoft JhengHei";font-siz=
e:
        11.0pt;color:#ED7D31' lang=3Den-US>(</span><span style=3D'font-weig=
ht:bold;
        font-family:"Microsoft JhengHei";font-size:11.0pt;color:#ED7D31'
        lang=3Dzh-TW>橘色那一欄第一個</span><span style=3D'font-wei=
ght:bold;font-family:
        "Microsoft JhengHei";font-size:11.0pt;color:#ED7D31' lang=3Den-US>)=
</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
en-US>(</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
zh-TW>如果同色太醜就紅橘相間</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
en-US>)</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
zh-TW>直接來複製顏色格式一定不會錯</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
en-US>xd</span></li>
   </ul>
  </ul>
 </ul>
 <p style=3D'margin:0in;margin-left:1.125in;font-family:"Microsoft JhengHei=
";
 font-size:11.0pt' lang=3Den-US>&nbsp;</p>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>流行病=
學（Epidemiology）</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-t=
op:
       5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-=
family:
       "Microsoft JhengHei";font-size:14.0pt'>VTE 包含深層靜脈血栓=
Deep Venous
       Thrombosis, DVT） 及肺栓塞（Pulmonary Embolism, PE），是全=
球重要的心血管疾病之一。</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>全球=
況</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bl=
ack'
        lang=3Den-US>美國每年約10萬至18萬人死於PE</span><span st=
yle=3D'font-family:"Microsoft JhengHei";
        font-size:11.0pt;color:black' lang=3Dzh-TW>，</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bl=
ack'
        lang=3Den-US>是住院患者最常見的可預防死亡原因。</s=
pan></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bl=
ack'>加拿大研究顯示，近半數PE患者於1年內出現運動受限=
步行距離減少、呼吸困難，影響生活品質。</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>台灣=
況</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bl=
ack'>台灣
        VTE 的確切盛行率不明，但根據衛福部統計，DVT和PE=
發生率在近年逐漸增加。</span></li>
   </ul>
  </ul>
 </ul>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>病因與=
危險因子（Etiology
      &amp; Risk Factors）</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>Virchow's
       Triad（三要素）</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-=
top:
        5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font=
-family:
        "Microsoft JhengHei";font-size:11.0pt'>VTE 的形成與三大因素=
有關：</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-=
size:
         11.0pt'>靜脈滯留（Venous Stasis）：長期臥床、久坐、=
飛行旅程等。</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-=
size:
         11.0pt'>高凝狀態（Hypercoagulability）：遺傳性或後天=
凝血異常（如 Factor V Leiden 突變）。</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-=
size:
         11.0pt'>血管內皮損傷（Endothelial Injury）：外傷、手=
、發炎等。</span></li>
    </ul>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>危險=
子</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bl=
ack'>遺傳因素：Factor
        V Leiden 突變、Prothrombin Gene 突變、抗凝血蛋白（Antit=
hrombin、Protein C/S）缺乏。</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bl=
ack'>後天因素：癌症、肥胖、抽菸、高血壓、慢性腎病（C=
KD）、慢性阻塞性肺病（COPD）、長途旅行、避孕藥、懷孕=
、手術、外傷等。</span></li>
   </ul>
  </ul>
 </ul>
 <p style=3D'margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
 font-size:11.0pt;color:black' lang=3Den-US>&nbsp;</p>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>病生理=
學（Pathophysiology）</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>血栓=
成機制</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt'>血栓=
成機制</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'><span
         style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=
=3Den-US>靜脈滯留</span><span
         style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=
=3Dzh-TW>，高凝血狀態和血管內皮損傷都會誘導</span><span
         style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=
=3Den-US>血小板釋放微粒（Microparticles），微粒與嗜中性球=
成Neutrophil
         Extracellular Traps, NETs，促進凝血</span><span style=3D'font=
-family:"Microsoft JhengHei";
         font-size:11.0pt' lang=3Dzh-TW>，造成血栓。</span></li>
    </ul>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt'>栓塞=
成</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'><span
         style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt'>深層=
靜脈血栓（DVT）如何導致肺栓塞（PE）？</span></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:black'><span
          style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=
=3Den-US>當</span><span
          style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=
=3Dzh-TW>
          DVT 血栓脫落</span><span style=3D'font-family:"Microsoft Jhen=
gHei";
          font-size:11.0pt' lang=3Den-US>，可隨靜脈血流經</span><sp=
an style=3D'font-family:
          "Microsoft JhengHei";font-size:11.0pt' lang=3Dzh-TW> 下腔靜脈=
（IVC）</span><span
          style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=
=3Den-US>，進入</span><span
          style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=
=3Dzh-TW>右心房（RA）→
          右心室（RV）→ 肺動脈（PA）</span><span style=3D'font-=
family:"Microsoft JhengHei";
          font-size:11.0pt' lang=3Den-US>，最終導致</span><span style=
=3D'font-family:
          "Microsoft JhengHei";font-size:11.0pt' lang=3Dzh-TW>急性 PE</sp=
an><span
          style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=
=3Den-US>。</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:black'><span
          style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=
=3Den-US>許多
          PE 患者可能沒有明顯的DVT，因為</span><span style=3D'f=
ont-family:"Microsoft JhengHei";
          font-size:11.0pt' lang=3Dzh-TW>血栓已經完全脫落並進入=
部，導致難以在下肢找到血栓。</span></li>
     </ul>
    </ul>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>肺栓=
的生理影響</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>氣體交換異常：低氧血症、死腔增加。</span><=
/li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>血流動力學異常：</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-=
size:
         11.0pt'>肺血管阻力（Pulmonary Vascular Resistance, PVR）上=
升，導致肺高壓。</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-=
size:
         11.0pt'>右心室（RV）擴張與功能不全，可能導致右=
衰竭。</span></li>
    </ul>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>肺功能異常：肺泡過度換氣、支氣管收縮、=
順應性降低。</span></li>
   </ul>
  </ul>
 </ul>
 <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:16.0pt;
 color:black' lang=3Den-US>&nbsp;</p>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt' lang=3Den=
-US>VTE的診斷</span><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt' lang=3Dzh=
-TW>：</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt' lang=3De=
n-US>VTE
       的診斷需要結合</span><span style=3D'font-family:"Microsoft Jh=
engHei";font-size:
       14.0pt' lang=3Dzh-TW>臨床表現（Clinical Evaluation）、實驗=
檢查（Laboratory
       Tests）、影像學（Imaging Studies），以確認深層靜脈血=
栓（DVT） 或 肺栓塞（PE） 的存在。</span></li>
  </ul>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>臨床表=
現（Clinical
      Presentation）</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>DVT 的=
狀</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bl=
ack'
        lang=3Den-US>單側</span><span style=3D'font-family:"Microsoft Jhe=
ngHei";
        font-size:11.0pt;color:#C00000' lang=3Den-US>小腿抽筋樣疼痛=
</span><span
        style=3D'font-family:Calibri;font-size:11.0pt;color:#C00000' lang=
=3Den-US>Charley
        Horse</span><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:
        11.0pt;color:#C00000' lang=3Den-US>）</span><span style=3D'font-fa=
mily:"Microsoft JhengHei";
        font-size:11.0pt;color:black' lang=3Dzh-TW>，且會隨時間加劇=
。（最常見）</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt'>小腿=
脹</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt'>皮膚=
紅或發熱</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt'>Homan's
        Sign（背屈足部時小腿疼痛）（敏感度低）</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>PE 的=
狀</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt'>不明=
因呼吸急促（最常見）</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt'>胸痛=
可能為胸膜炎樣疼痛）</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt'>低血=
、呼吸性鹼中毒</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt'>嚴重=
可能發生休克、右心衰竭、猝死</span></li>
   </ul>
  </ul>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>風險評=
估</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>Wells Sc=
ore
       是最常用來評估DVT 和 PE風險的臨床決策工具。 </span=
></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C=
00000'>Wells
        Score for DVT</span></li>
   </ul>
  </ul>
 </ul>
 <div style=3D'direction:ltr'>
 <table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'di=
rection:ltr;
  border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-w=
idth:
  1pt;margin-left:1.0833in' title=3D"" summary=3D"">
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.6868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'>臨床變項</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'>分數</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.6868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>活躍性癌症</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.6868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>癱瘓、偏癱，或近期石膏固定</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.6868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'><span
   lang=3Dzh-TW>臥床 &gt;3 天或12</span><span lang=3Den-US> </span><spa=
n lang=3Dzh-TW>週內接受大手術</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.6868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>深靜脈分布區域壓痛</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.6868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>整條腿腫脹</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.7062in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>單側小腿腫脹
   &gt;3 cm（與對側比較）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.6868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>凹陷性水腫（Pitting
   Edema）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.6868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>側枝靜脈擴張（非靜脈曲張）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.6868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>其他診斷與
   DVT 一樣可能</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'><span
   style=3D'font-weight:bold'>-2</span></p>
   </td>
  </tr>
 </table>
 </div>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-to=
p:
      5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-f=
amily:
      "Microsoft JhengHei";font-size:11.0pt'><span
      style=3D'mso-spacerun:yes'> </span>評估結果：</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bla=
ck'>低風險：0
       分或更低</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bla=
ck'>中等風險：1-2
       分</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bla=
ck'
       lang=3Den-US>高風險：</span><span style=3D'font-family:"Cambria =
Math";
       font-size:11.0pt;color:black' lang=3D"x-IV_mathan">≥</span><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bla=
ck'
       lang=3Den-US>3 分</span></li>
  </ul>
 </ul>
 <p style=3D'margin:0in;margin-left:1.5in;font-family:"Microsoft JhengHei";
 font-size:11.0pt;color:black' lang=3Den-US>&nbsp;</p>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt'>Wells Sco=
re for
      PE</span></li>
 </ul>
 <div style=3D'direction:ltr'>
 <table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'di=
rection:ltr;
  border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-w=
idth:
  1pt;margin-left:1.0833in' title=3D"" summary=3D"">
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.668in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'>臨床變項</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'>分數</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.668in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>DVT
   臨床表現</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+3</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.668in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>其他診斷可能性較
   PE 低</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+3</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.668in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>心跳
   &gt;100 次/分</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1.5</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.6875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>**臥床超過
   3 天 或 4 週內接受大手術</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1.5</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.668in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>既往
   PE 或 DVT 病史</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1.5</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.668in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>咳血（Hemoptysis）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.668in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>惡性腫瘤（Active
   Cancer）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>+1</p>
   </td>
  </tr>
 </table>
 </div>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-to=
p:
      5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-f=
amily:
      "Microsoft JhengHei";font-size:11.0pt'>評估結果：</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bla=
ck'
       lang=3Den-US>低風險（</span><span style=3D'font-family:"Cambria =
Math";
       font-size:11.0pt;color:black' lang=3D"x-IV_mathan">≤</span><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bla=
ck'
       lang=3Den-US>4 分）： 建議先檢測 </span><span style=3D'font-=
family:"Microsoft JhengHei";
       font-size:11.0pt;color:#C00000' lang=3Den-US>D-dimer</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bla=
ck'
       lang=3Den-US>高風險（&gt;4 分）： 建議</span><span style=3D=
'font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:#C00000' lang=3Den-US>直接進行影像學=
查</span><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bla=
ck'
       lang=3Den-US>（CT 肺血管攝影）</span><span style=3D'font-fami=
ly:Calibri;font-size:
       11.0pt' lang=3Dzh-TW><br>
              </span>&nbsp;</li>
  </ul>
 </ul>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>實驗室=
檢測（Laboratory
      Tests）</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:bla=
ck'>D-dimer
       檢測：</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bl=
ack'>高敏感度（&gt;95%），但特異性低（許多其他疾病也會=
升高）。</span></li>
   </ul>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>用於排除 PE 或 DVT，而非確診。</span></li>
   </ul>
  </ul>
 </ul>
 <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt'>=
<br>
  &nbsp;</p>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>影像學=
檢查（Imaging
      Studies）</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>深層=
脈血栓（DVT）診斷</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>靜脈超音波（Venous Ultrasonography）（首選）</sp=
an></li>
   </ul>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bl=
ack'>主要依據</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C=
00000'>靜脈壓縮性降低</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bl=
ack'>（Vein
        Compressibility Loss）判斷。</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>肺栓=
（PE）診斷</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C=
00000'>CT
        肺血管攝影（CT Pulmonary Angiography, CTPA）（首選）</sp=
an></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
         style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:b=
lack'>具高度特異性，可直接觀察肺動脈內的血栓。</span></=
li>
    </ul>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bl=
ack'>V/Q
        scan（通氣/灌注掃描）</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
         style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:b=
lack'>適用於
         腎功能不佳或對比劑過敏患者。</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
         style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:b=
lack'>高灌注缺陷
         + 正常通氣 =3D 高度懷疑 PE。</span></li>
    </ul>
   </ul>
  </ul>
 </ul>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt;color:blac=
k'>鑑別診斷（Differential
      Diagnosis）</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-t=
op:
       5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-=
family:
       "Microsoft JhengHei";font-size:14.0pt'>PE 可與以下疾病混淆=
</span></li>
  </ul>
 </ul>
 <div style=3D'direction:ltr'>
 <table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'di=
rection:ltr;
  border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-w=
idth:
  1pt;margin-left:.7083in' title=3D"" summary=3D"">
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.8784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'>疾病</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.0756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'>鑑別特徵</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.8784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>肺炎（Pneumonia）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1451in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>發燒、痰液、肺部
   X 光浸潤影</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.8784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>心肌梗塞（MI）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.0756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>心電圖異常、心臟酵素升高</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.8979in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>氣胸（Pneumothorax）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>突發單側胸痛，聽診無呼吸音</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.8784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>心包炎（Pericarditis）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1451in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>胸痛隨體位改變，心包摩擦音</p>
   </td>
  </tr>
 </table>
 </div>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-to=
p:
      5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-f=
amily:
      "Microsoft JhengHei";font-size:11.0pt;color:black'>此外，DVT 也=
與</span><span
      style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00=
000'>Baker
      囊腫破裂、蜂窩組織炎（Cellulitis）、急性靜脈功能=
全（Acute Venous Insufficiency）</span><span
      style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:blac=
k'>
      等區分。</span></li>
 </ul>
 <p style=3D'margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
 font-size:11.0pt;color:black' lang=3Den-US>&nbsp;</p>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>治療（=
Treatment）</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>抗凝=
療（Anticoagulation）</span></li>
  </ul>
 </ul>
 <div style=3D'direction:ltr'>
 <table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'di=
rection:ltr;
  border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-w=
idth:
  1pt;margin-left:.7083in' title=3D"" summary=3D"">
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:black;text-align:center'>藥物</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.5868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:black;text-align:center'>機轉</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.4972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:black;text-align:center'>主要適應症</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:black'>Heparin (UFH, LMWH)</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.5868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:black'>抑制凝血因子 Xa 和 IIa</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.4694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:black'>急性 DVT/PE</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:black'>Warfarin</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.6062in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:black'>抑制維生素 K 依賴性凝血因子</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.4687in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:black'>長期抗凝治療</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:black'>DOACs (Rivaroxaban, Apixaban, Dabigatran)</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.5868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:black'>直接抑制凝血因子 Xa 或 IIa</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.5277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:black'>無需監測 INR，可用於長期抗凝</p>
   </td>
  </tr>
 </table>
 </div>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>其他治=
療</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bla=
ck'>血栓溶解劑（Thrombolysis）：適用於低血壓或嚴重
       PE。</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bla=
ck'>下腔靜脈濾網（IVC
       filter）：適用於無法使用抗凝劑者。</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:bla=
ck'>手術取栓（Embolectomy）：適用於急性大面積
       PE 且抗凝無效者。</span></li>
  </ul>
 </ul>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>預後與=
預防（Prognosis
      &amp; Prevention）</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:bla=
ck'>若未治療，DVT
       50%可能發展為 PE，PE則可能導致猝死。</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:bla=
ck'>預防措施：早期活動、壓力襪、藥物預防（Heparin,
       DOACs）。</span></li>
  </ul>
 </ul>
 <p style=3D'margin:0in;margin-left:.75in;font-family:"Microsoft JhengHei";
 font-size:11.0pt;color:black'>&nbsp;</p>
 <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
 color:black'>REFERENCE：</p>
 <ol type=3D1 style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;marg=
in-bottom:
  0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:no=
rmal'>
  <li value=3D1 style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;
      color:black' lang=3Den-US><span style=3D'font-family:"Microsoft Jheng=
Hei";
      font-size:11.0pt;font-weight:normal;font-style:normal;font-family:"Mi=
crosoft JhengHei";
      font-size:11.0pt'>《Harrison's Principles of Internal Medicine, 20th
      Edition》</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'
      lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-siz=
e:11.0pt'>《Washington
      Manual of Medical Therapeutics, 36th Edition》</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'
      lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-siz=
e:11.0pt'>USMLE
      Step 2 CK 相關資料</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:blac=
k'
      lang=3Den-US>台灣疾病管制署（</span><a href=3D"https://data.c=
dc.gov.tw"><span
      style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt;color:blac=
k'
      lang=3Den-US>https://data.cdc.gov.tw</span></a><span style=3D'font-fa=
mily:
      "Microsoft JhengHei";font-size:11.0pt;color:black' lang=3Den-US>）</=
span></li>
 </ol>
 <p style=3D'margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
 font-size:11.0pt'>&nbsp;</p>
 <p style=3D'margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
 font-size:16.0pt;color:#C00000'><span style=3D'font-weight:bold'>修改內=
容</span></p>
 <p style=3D'margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
 font-size:11.0pt'>&nbsp;</p>
 <h3 style=3D'margin:0in;margin-left:.375in;font-size:12.0pt'><span
 style=3D'font-family:"Microsoft JhengHei";color:#1F3763'>DOAC的表格對=
要有喔</span><span
 style=3D'font-family:Calibri;color:#1F3763'><br>
  </span><span style=3D'font-family:"Microsoft JhengHei";color:#1F3763'><br>
  </span><span style=3D'font-family:Calibri;color:black'>DOACs </span><span
 style=3D'font-family:"Microsoft JhengHei";color:black'>對照總表</span>=
</h3>
 <div style=3D'direction:ltr'>
 <table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'di=
rection:ltr;
  border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-w=
idth:
  1pt;margin-left:.3333in' title=3D"" summary=3D"">
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.7291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>藥物名稱</span><=
/p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8986in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>分類 / 機轉</spa=
n></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.7256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>常見商品名</spa=
n></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.9118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>主要適應症</spa=
n></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.0986in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>常用劑量</span><=
/p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>主要副作用</spa=
n></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.0458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>特殊注意事項</=
span></p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.7166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style=3D'font-weight:bold'>Rivaroxaban</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>Factor Xa =
制劑</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.7062in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>Xarelto</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.9215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>-
   VTE（DVT/PE）治療與預防<br>
      - 非瓣膜性 AF 中風預防<br>
      - 術後 VTE 預防（髖/膝關節置換）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>- 起始：=
15 mg BID ×
   21 天<br>
      - 維持：20 mg QD</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>- 出血<br>
      - 肝功能異常</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.0458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>- 隨餐服=
用吸收佳<br>
      - 腎功能不佳需調整劑量（CrCl &lt; 30 禁用）</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.7291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style=3D'font-weight:bold'>Apixaban</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>Factor Xa =
制劑</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.7062in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>Eliquis</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.9215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>-
   VTE（DVT/PE）治療與預防<br>
      - 非瓣膜性 AF 中風預防<br>
      - 術後 VTE 預防</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>- 起始：=
10 mg BID ×
   7 天<br>
      - 維持：5 mg BID</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>- 出血（=
相對較低）<br>
      - 噁心、腹瀉</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.0458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>- 出血風=
險最低<br>
      - 腎功能不佳（CrCl &lt; 15 建議避免）</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.7291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style=3D'font-weight:bold'>Edoxaban</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>Factor Xa =
制劑</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.7062in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>Lixiana</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.9215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>-
   VTE（DVT/PE）治療<br>
      - 非瓣膜性 AF 中風預防</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>- 60 mg QD=
治療前需用
   parenteral anticoagulation ≥5天）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>- 出血<br>
      - 肝酵素上升</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.0458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>- CrCl &gt;=
95
   ml/min：不建議用於 AF（因 stroke 保護力下降）</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.7291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style=3D'font-weight:bold'>Dabigatran</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>Direct Thro=
mbin
   (Factor IIa) 抑制劑</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.7256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>Pradaxa</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.9215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>- VTE 治=
與預防<br>
      - 非瓣膜性 AF 中風預防<br>
      - 術後 VTE 預防</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>- 起始需=
 parenteral
   anticoagulation（5–10天）<br>
      - 維持：150 mg BID</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>- 出血<br>
      - 消化道不適（胃灼熱）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.0458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>-
   需保存在乾燥原瓶中（受濕氣影響）<br>
      - 腎功能差者慎用（CrCl &lt; 30 避免）<br>
      - 有解毒劑（Idarucizumab）</p>
   </td>
  </tr>
 </table>
 </div>
 <h3 style=3D'margin:0in;margin-left:.375in;font-family:Calibri;font-size:1=
2.0pt;
 color:black'>DOACs 各藥物代謝途徑、腎肝功能限制整理表</h3>
 <div style=3D'direction:ltr'>
 <table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'di=
rection:ltr;
  border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-w=
idth:
  1pt;margin-left:.3333in' title=3D"" summary=3D"">
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>藥物名稱</span><=
/p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.5229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>主要代謝與排=
途徑</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.1902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>腎功能不佳（Cr=
Cl&lt;30）</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.3284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>肝功能異常（Ch=
ild-Pugh B/C）</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.0638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>臨床備註</span><=
/p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style=3D'font-weight:bold'>Dabigatran</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.5131in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>非酵素代謝，含<span
   style=3D'color:#C00000'> </span><span style=3D'font-weight:bold;color:#C=
00000'>Hofmann
   elimination</span><br>
      <span style=3D'color:#C00000'>約 80% 腎臟排除</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.1902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>不建議使用</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.3284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>慎用，若凝血功能異常應避免</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.0722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>有專一解毒劑
   Idarucizumab</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style=3D'font-weight:bold'>Rivaroxaban</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.5326in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>肝臟代謝為主（CYP3A4,
   CYP2J2）<br>
      約 35% 腎排除</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.1902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>不建議使用</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.3284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>不建議使用</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.0722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>隨餐服用吸收最佳</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style=3D'font-weight:bold'>Apixaban</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.5131in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>肝臟代謝為主（CYP3A4）<br>
      約 25% 腎排除</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.1902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>可使用，但需劑量調整</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.3284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>不建議使用</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.0722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>出血風險相對較低</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.8256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style=3D'font-weight:bold'>Edoxaban</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.5131in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>約
   50% 腎排除，少量肝代謝</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.2097in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>CrCl &lt;15
   禁用<br>
      CrCl &gt;95 避免用於 AF 預防</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.3284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>不建議使用</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:1.0722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>使用前建議先打針抗凝5天</p>
   </td>
  </tr>
 </table>
 </div>
 <p style=3D'margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
 font-size:11.0pt'>&nbsp;</p>
</ul>

</div>

</div>

</div>

<div>

<p style=3D'margin:0in'>&nbsp;</p>

<p style=3D'text-align:left;margin:0in;font-family:Arial;font-size:9pt;
color:#969696;direction:ltr'>使用 OneNote 建立。</p>

</div>

</body>

</html>
